INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 447m ago
HOUSE PTR46m ago
SEC 13F46m ago
ROBINHOOD CHAIN46m ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Olivo Alicia C sold NEO

EVP, GC & Business Development · NEOGENOMICS INC · Common Stock

Side
SELL
Value
$251K
Shares
20.9K
Price
$12
Executed
Nov 25, 2025
Disclosed
Nov 28, 2025
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Nov 25 executedNov 28, 2025 disclosed

NEO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
25/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+15 / 25

    $251K reported value · 40.2% of prior position

  • Filing timing+6 / 15

    Disclosed 3 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NEO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    28
    Gilbert Ray Cisneros, Jr.DSelf
    NEONEOGENOMICS INC
    Purchase
    		BUY$1,001 – $15KAug 7, 2026Sep 10, 2026
    traded Aug 7, 2026
    		+34dHOUSE PTR

    Evidence

    13
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    17
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    21
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    16
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M$90K
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M—
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-25-054270
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 25, 2025
    Published
    Nov 28, 2025
    Ingested by INSIDER
    Nov 5, 04:30 UTC
    Last re-read
    Nov 5, 04:30 UTC

    Extracted facts

    Filer
    Olivo Alicia C
    Role
    EVP, GC & Business Development
    Transaction
    Open-market saleAs filed: “S”
    Asset
    NEOGENOMICS INC
    Ticker
    NEO
    Shares
    20.9K
    Price per share
    $12
    Value
    $250,992
    Execution date (reported)
    Nov 25, 2025
    Owned after transaction
    31.1K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    3

    Calculation

    Value = shares × reported price per share

    • Shares: 20.9K
    • Price: $12

    = $250,992

    What this establishes

    Olivo Alicia C filed this Form 4 reporting a open-market sale of NEO on Nov 25, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP, GC & Business Development
    Olivo Alicia Ccik:0001951869
    Issuer
    NEOGENOMICS INCcik:0001077183

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.